Company Filing History:
Years Active: 2018-2019
Title: The Innovations of Dinglong Wu
Introduction
Dinglong Wu is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of biomedicine, particularly through his innovative approaches to protein modification. With a total of 2 patents, his work focuses on enhancing the stability and bioactivity of multimeric proteins.
Latest Patents
Dinglong Wu's latest patents include the "Use of multi-arm polyethylene glycol modifier and application of multi-arm polyethylene glycol modifier in L-asparaginase modification." This invention describes methods for using a multi-arm polyethylene glycol (PEG) modifier to improve the stability of multimeric proteins. The PEG modifier enhances subunit interaction, thereby maintaining the protein in a polymerized form and reducing immunogenicity. Another significant patent is "Pegylated tissue kallikrein, and preparation method therefor and uses thereof." This invention relates to PEG-modified protein drugs, specifically a PEGylated tissue kallikrein that offers extended half-life and reduced immunogenicity, making it particularly effective in treating conditions such as cerebral apoplexy and diabetic nephropathy.
Career Highlights
Dinglong Wu has worked with prominent organizations in the biopharmaceutical sector. He has been associated with Zonhon Biopharma Institute, Inc. and Gensun Institute of Biomedicine Co., Ltd. His work in these institutions has allowed him to develop and refine his innovative approaches to protein modification.
Collaborations
Throughout his career, Dinglong Wu has collaborated with notable professionals in the field, including Bruce Yong Ma and Jun Wang. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Dinglong Wu's contributions to biomedicine through his innovative patents demonstrate his commitment to enhancing protein stability and bioactivity. His work continues to have a significant impact on the field, paving the way for advancements in therapeutic applications.